Analyzing Ratios: NKGen Biotech Inc (NKGN)’s Financial Story Unveiled

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of NKGen Biotech Inc (NASDAQ: NKGN) closed at $0.35 in the last session, down -12.32% from day before closing price of $0.40. In other words, the price has decreased by -$12.32 from its previous closing price. On the day, 1.09 million shares were traded. NKGN stock price reached its highest trading level at $0.41 during the session, while it also had its lowest trading level at $0.331.

Ratios:

We take a closer look at NKGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.02 and its Current Ratio is at 0.02.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 07 ’23 when Song Paul Y. bought 76 shares for $3.29 per share. The transaction valued at 250 led to the insider holds 171,121 shares of the business.

Song Paul Y. bought 75 shares of NKGN for $250 on Dec 06 ’23. The Chief Executive Officer now owns 171,045 shares after completing the transaction at $3.32 per share. On Dec 04 ’23, another insider, Song Paul Y., who serves as the Chief Executive Officer of the company, bought 163 shares for $3.07 each. As a result, the insider paid 500 and bolstered with 170,864 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NKGN now has a Market Capitalization of 13607440 and an Enterprise Value of 40389832.

Stock Price History:

Over the past 52 weeks, NKGN has reached a high of $5.10, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -35.79%, while the 200-Day Moving Average is calculated to be -71.63%.

Shares Statistics:

According to the various share statistics, NKGN traded on average about 1.01M shares per day over the past 3-months and 5062500 shares per day over the past 10 days. A total of 21.89M shares are outstanding, with a floating share count of 18.20M. Insiders hold about 48.77% of the company’s shares, while institutions hold 13.32% stake in the company. Shares short for NKGN as of 1728950400 were 432022 with a Short Ratio of 0.43, compared to 1726185600 on 680883. Therefore, it implies a Short% of Shares Outstanding of 432022 and a Short% of Float of 4.3.

Most Popular